Neurocrine Biosciences' valbenazine shows promise as an adjunctive therapy for Schizophrenia, with phase 3 data expected in ...

Coherus BioSciences is now heavily focused on developing its pipeline, particularly casdozokitug and CHS-114. See why I rate ...

LIfT Biosciences is a UK & Ireland biotech moving into clinical trials for their first-in-class unique allogeneic neutrophil based cell therapy that rejuvenates immune competence and overcomes ...

Alpha-1-antitrypsin is a so-called protease inhibitor, a type of enzyme inhibitor. It is produced in the liver but exerts its effects in the lungs, where it regulates immune cell activity. This ...

In this article, we are going to take a look at where Avidity Biosciences ... However, high excess returns (alpha) are challenging to generate, let alone doubling money. For example, if someone ...

Anixa Biosciences (ANIX) announced that the United States Patent and Trademark Office has issued a Notice of Allowance for a new patent related ...

Spruce Biosciences (SPRB) announced the company’s new corporate strategy and acquisition of tralesinidase alfa enzyme replacement therapy for ...